Sequoia, Eastern Bell Co-Lead $42M Series C Round In Chinese CRO Service Provider

Yaoyanshe, a Chinese clinical research organization (CRO) service provider, has raised RMB300 million (US$42.61 million) in a series C round of financing led by Chinese venture capital firm Eastern Bell Capital and Sequoia Capital China.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets